企業プロフィール
iTeos Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- ITOS
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Belgium and listed in the U
株価変動の要因
Current closing-price context is not available for ITOS.
企業概要
事業概要
iTeos Therapeutics is an immuno-oncology company developing therapies that modulate the tumor microenvironment. Its pipeline is aimed at creating better cancer immunotherapy combinations.
所在地とセクター分類
Headquartered in Belgium and listed in the U.S. as an ADR, iTeos has a global oncology-biotech profile.
ビジネスモデルの特徴
The business depends on clinical data, partnership economics, and the ability to create differentiated oncology assets.
バイオ業界での位置付け
iTeos is a catalyst-heavy immuno-oncology name whose stock reacts quickly to data and strategic developments.
今後のカタリスト
- iTeos Therapeutics's catalysts are belrestotug and the rest of its immuno-oncology pipeline, where the next clinical update will determine whether the platform still has momentum. The company remains very data-sensitive.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。